PRUCALOPRIDE

PRUCALOPRIDE was reported 2370 times

PRUCALOPRIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AIRWAY PEAK PRESSURE 1 0.1667
1 ANAESTHESIA PROCEDURE 2 0.1053
2 ADJUSTMENT DISORDER WITH DISTURBANCE OF CONDUCT 1 0.0714
3 LARYNGECTOMY 5 0.0625
4 BRONCHIAL DYSPLASIA 1 0.0526
5 OVERFLOW DIARRHOEA 2 0.0250
6 DUPLICATE THERAPY ERROR 8 0.0249
7 MITOCHONDRIAL MYOPATHY 5 0.0229
8 PELVIC ORGAN PROLAPSE 2 0.0220
9 BLOOD PRESSURE AMBULATORY INCREASED 1 0.0217
10 DELIRIUM TREMENS 8 0.0198
11 MOROSE 3 0.0175
12 BASILAR MIGRAINE 1 0.0159
13 PITUITARY TUMOUR BENIGN 25 0.0153
14 GASTROINTESTINAL BACTERIAL OVERGROWTH 9 0.0150
15 CARBOHYDRATE INTOLERANCE 1 0.0147
16 ABDOMINAL MIGRAINE 1 0.0147
17 GASTROINTESTINAL MICROORGANISM OVERGROWTH 5 0.0142
18 INABILITY TO AFFORD MEDICATION 136 0.0137
19 SUPERIOR MESENTERIC ARTERY SYNDROME 3 0.0135
20 SERUM AMYLOID A PROTEIN INCREASED 2 0.0129
21 INCREASED DOSE ADMINISTERED 4 0.0128
22 BREAST PROSTHESIS REMOVAL 1 0.0123
23 BLOOD COPPER DECREASED 1 0.0122
24 SECONDARY ADRENOCORTICAL INSUFFICIENCY 17 0.0113
25 FEEDING TUBE USER 4 0.0109
26 ANAL POLYP 1 0.0097
27 ADJUSTED CALCIUM DECREASED 1 0.0094
28 POST VIRAL FATIGUE SYNDROME 2 0.0083
29 BLOOD GASTRIN INCREASED 1 0.0078
30 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
31 AUTOMATIC BLADDER 1 0.0072
32 INSURANCE ISSUE 109 0.0071
33 CARCINOID TUMOUR OF THE STOMACH 1 0.0071
34 CATHETER SITE CELLULITIS 2 0.0068
35 BONE LESION EXCISION 1 0.0066
36 BONE MARROW MYELOGRAM ABNORMAL 1 0.0057
37 DEVICE USE CONFUSION 3 0.0057
38 MAST CELL ACTIVATION SYNDROME 8 0.0057
39 FOREIGN BODY IN GASTROINTESTINAL TRACT 2 0.0055
40 MACROCYTOSIS 6 0.0052
41 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
42 ADULTERATED PRODUCT 1 0.0050
43 SCAR PAIN 2 0.0050
44 CATARACT SUBCAPSULAR 3 0.0049
45 GASTROINTESTINAL HYPOMOTILITY 11 0.0049
46 MUSCULAR DYSTROPHY 2 0.0046
47 DEFAECATION DISORDER 3 0.0045
48 BODY MASS INDEX DECREASED 2 0.0043
49 BRONCHOSCOPY 1 0.0042
50 INFUSION SITE HAEMATOMA 2 0.0042
51 INFUSION SITE RASH 5 0.0036
52 ATOPY 1 0.0036
53 PERIORBITAL PAIN 3 0.0035
54 BOWEL MOVEMENT IRREGULARITY 27 0.0035
55 IMPAIRED GASTRIC EMPTYING 48 0.0035
56 BACTERIAL VULVOVAGINITIS 1 0.0035
57 INTESTINAL PSEUDO-OBSTRUCTION 3 0.0034
58 GASTROINTESTINAL MOTILITY DISORDER 18 0.0034
59 INFUSION RELATED HYPERSENSITIVITY REACTION 2 0.0033
60 MEDICAL DEVICE SITE INFECTION 2 0.0032
61 INCREASED VISCOSITY OF BRONCHIAL SECRETION 2 0.0031
62 HYPERPROLACTINAEMIA 20 0.0031
63 BOREDOM 1 0.0029
64 GASTRIC PH DECREASED 3 0.0029
65 NONINFECTIVE ENCEPHALITIS 2 0.0028
66 BIPOLAR II DISORDER 1 0.0028
67 ANASTOMOTIC STENOSIS 1 0.0027
68 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
69 CATHETER SITE EXTRAVASATION 1 0.0025
70 CAT SCRATCH DISEASE 1 0.0025
71 TONGUE ERYTHEMA 2 0.0024
72 INFREQUENT BOWEL MOVEMENTS 6 0.0024
73 INFUSION SITE DISCHARGE 4 0.0023
74 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
75 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
76 CEREBRAL PALSY 2 0.0021
77 INFUSION SITE NODULE 2 0.0021
78 NOROVIRUS INFECTION 3 0.0021
79 STOMA SITE PAIN 3 0.0020
80 BODY HEIGHT INCREASED 1 0.0020
81 INFUSION SITE INDURATION 3 0.0020
82 GASTROINTESTINAL WALL THICKENING 3 0.0020
83 GASTROINTESTINAL TUBE INSERTION 5 0.0020
84 PRODUCT AVAILABILITY ISSUE 45 0.0020
85 DYSCHEZIA 6 0.0020
86 TEETH BRITTLE 2 0.0019
87 HYPERKINESIA 4 0.0019
88 BURSITIS INFECTIVE 1 0.0018
89 INFUSION SITE MASS 2 0.0018
90 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
91 BLOOD GROWTH HORMONE INCREASED 1 0.0018
92 STRESS AT WORK 2 0.0018
93 VITAMIN D DEFICIENCY 17 0.0017
94 MUCOSAL HAEMORRHAGE 2 0.0017
95 SINUS OPERATION 4 0.0017
96 MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0017
97 RECTAL PROLAPSE 2 0.0017
98 INFUSION SITE WARMTH 2 0.0016
99 HYPERTENSIVE HEART DISEASE 3 0.0016
100 BLADDER SPASM 3 0.0016
101 INFUSION SITE PRURITUS 5 0.0016
102 ANAL INFLAMMATION 1 0.0016
103 BLADDER IRRITATION 1 0.0016
104 ABDOMINAL OPERATION 2 0.0015
105 STOMA SITE INFECTION 2 0.0015
106 THERAPEUTIC PRODUCT EFFECT DELAYED 7 0.0015
107 CATATONIA 8 0.0015
108 INTESTINAL DILATATION 2 0.0015
109 ANAL INCONTINENCE 13 0.0014
110 INFUSION SITE SWELLING 9 0.0014
111 SLEEP DEFICIT 3 0.0014
112 GLUTEN SENSITIVITY 2 0.0014
113 PRODUCT DISTRIBUTION ISSUE 13 0.0014
114 PULMONARY VALVE INCOMPETENCE 2 0.0014
115 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
116 PRODUCT COLOUR ISSUE 7 0.0014
117 BLUNTED AFFECT 1 0.0014
118 BACTERIAL TEST POSITIVE 3 0.0013
119 ARTERIAL INJURY 1 0.0013
120 PRODUCT PRESCRIBING ISSUE 29 0.0013
121 CHRONIC GASTRITIS 3 0.0013
122 RENAL COLIC 3 0.0013
123 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
124 VASCULAR DEVICE INFECTION 6 0.0013
125 ADRENAL INSUFFICIENCY 16 0.0013
126 ORAL SURGERY 3 0.0013
127 BREAST FEEDING 1 0.0013
128 BACTERIAL VAGINOSIS 2 0.0013
129 MEGACOLON 2 0.0013
130 OPHTHALMOPLEGIA 2 0.0013
131 ON AND OFF PHENOMENON 7 0.0013
132 URINARY HESITATION 3 0.0013
133 PAINFUL RESPIRATION 3 0.0012
134 HAEMATOLOGICAL INFECTION 3 0.0012
135 INFUSION SITE HAEMORRHAGE 4 0.0012
136 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
137 SOCIAL PROBLEM 5 0.0012
138 SYSTEMIC INFECTION 2 0.0012
139 GASTRIC DILATATION 2 0.0012
140 TONSILLECTOMY 2 0.0012
141 EYELID IRRITATION 3 0.0012
142 ALLERGIC SINUSITIS 1 0.0012
143 SERUM FERRITIN DECREASED 2 0.0012
144 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
145 SPINAL CORD INJURY 2 0.0011
146 PANCREATIC FAILURE 2 0.0011
147 DEVICE ALARM ISSUE 2 0.0011
148 SCLERODERMA 4 0.0011
149 ABNORMAL FAECES 9 0.0011
150 BONE CONTUSION 1 0.0011
151 PNEUMONIA KLEBSIELLA 2 0.0011
152 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
153 FREEZING PHENOMENON 4 0.0011
154 ADENOCARCINOMA GASTRIC 1 0.0011
155 ADVERSE FOOD REACTION 1 0.0011
156 AURA 2 0.0011
157 STENOSIS 2 0.0011
158 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0011
159 PARANASAL SINUS DISCOMFORT 4 0.0011
160 LIP DISORDER 2 0.0011
161 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
162 FAECES HARD 4 0.0010
163 EMERGENCY CARE 3 0.0010
164 AUTONOMIC NEUROPATHY 1 0.0010
165 EYELID PAIN 2 0.0010
166 VASCULAR STENT THROMBOSIS 2 0.0010
167 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
168 CHANGE OF BOWEL HABIT 2 0.0010
169 BONE MARROW OEDEMA 1 0.0010
170 NO ADVERSE EVENT 175 0.0010
171 AXILLARY MASS 1 0.0010
172 MALABSORPTION 5 0.0010
173 INFUSION SITE ERYTHEMA 8 0.0009
174 NEUROGENIC BLADDER 2 0.0009
175 BONE DEMINERALISATION 1 0.0009
176 ANORECTAL DISCOMFORT 5 0.0009
177 PROCTALGIA 6 0.0009
178 INFUSION SITE BRUISING 2 0.0009
179 SPUTUM INCREASED 2 0.0009
180 IMMOBILE 4 0.0009
181 PULMONARY FUNCTION TEST DECREASED 4 0.0009
182 FAECALOMA 5 0.0009
183 COLONOSCOPY 2 0.0009
184 LARGE INTESTINAL OBSTRUCTION 2 0.0009
185 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
186 BLOOD FIBRINOGEN DECREASED 1 0.0009
187 BRAIN OPERATION 2 0.0009
188 ADMINISTRATION SITE PAIN 1 0.0009
189 REACTION TO EXCIPIENT 2 0.0009
190 FLATULENCE 49 0.0009
191 NECK SURGERY 2 0.0009
192 DEFAECATION URGENCY 6 0.0009
193 VOLVULUS 2 0.0008
194 EOSINOPHIL COUNT DECREASED 2 0.0008
195 HEREDITARY ANGIOEDEMA 9 0.0008
196 BRONCHIAL HYPERREACTIVITY 1 0.0008
197 WRONG DOSE 2 0.0008
198 BLADDER PROLAPSE 1 0.0008
199 RETINAL TEAR 2 0.0008
200 CEREBRAL DISORDER 6 0.0008
201 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
202 BLOOD UREA DECREASED 1 0.0008
203 BLADDER DISCOMFORT 1 0.0008
204 ABDOMINAL DISTENSION 83 0.0008
205 FACE INJURY 3 0.0008
206 BRONCHIAL SECRETION RETENTION 1 0.0008
207 ILEOSTOMY 2 0.0008
208 ADNEXA UTERI PAIN 1 0.0008
209 PRODUCT DISPENSING ERROR 17 0.0008
210 OESOPHAGEAL DISORDER 3 0.0008
211 ADENOCARCINOMA PANCREAS 1 0.0008
212 ANAEMIA POSTOPERATIVE 1 0.0008
213 URINE OUTPUT INCREASED 2 0.0008
214 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
215 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
216 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
217 ENURESIS 3 0.0007
218 SHOULDER ARTHROPLASTY 2 0.0007
219 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
220 RHINALGIA 2 0.0007
221 SELF-INJURIOUS IDEATION 3 0.0007
222 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
223 SEASONAL ALLERGY 10 0.0007
224 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
225 RESPIRATORY SYMPTOM 2 0.0007
226 DEVICE POWER SOURCE ISSUE 2 0.0007
227 PULMONARY PAIN 2 0.0007
228 INFUSION SITE REACTION 2 0.0007
229 IRON DEFICIENCY 3 0.0007
230 CENTRAL VENOUS CATHETERISATION 2 0.0007
231 AGE-RELATED MACULAR DEGENERATION 1 0.0007
232 CONSTIPATION 143 0.0007
233 SPINAL OPERATION 8 0.0006
234 HYPOMAGNESAEMIA 9 0.0006
235 ILEUS 8 0.0006
236 BRAIN FOG 10 0.0006
237 GASTROINTESTINAL PAIN 7 0.0006
238 PRODUCT USE COMPLAINT 10 0.0006
239 PRODUCT PACKAGING ISSUE 6 0.0006
240 BLADDER PAIN 2 0.0006
241 PRODUCT USE ISSUE 116 0.0006
242 INTESTINAL OBSTRUCTION 23 0.0006
243 NEAR DEATH EXPERIENCE 2 0.0006
244 INJECTION SITE INFLAMMATION 3 0.0006
245 BLOOD CALCIUM ABNORMAL 1 0.0006
246 VEIN DISORDER 3 0.0006
247 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
248 HEPATIC CYST 2 0.0006
249 PRODUCT PRESCRIBING ERROR 14 0.0006
250 MIGRAINE 56 0.0006
251 MUSCLE RIGIDITY 7 0.0006
252 PRODUCT CONTAINER ISSUE 5 0.0006
253 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
254 REGURGITATION 2 0.0006
255 THERAPEUTIC PRODUCT EFFECT DECREASED 26 0.0006
256 BLOOD CHLORIDE INCREASED 1 0.0006
257 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
258 DEPRESSION SUICIDAL 2 0.0006
259 HUNGER 8 0.0006
260 HYPERREFLEXIA 2 0.0006
261 ERYTHEMA NODOSUM 2 0.0006
262 MACULOPATHY 2 0.0006
263 INJECTION SITE DISCHARGE 3 0.0006
264 PRODUCT RESIDUE PRESENT 3 0.0006
265 FREQUENT BOWEL MOVEMENTS 15 0.0006
266 JAW DISORDER 3 0.0005
267 INTENTIONAL UNDERDOSE 4 0.0005
268 NONSPECIFIC REACTION 3 0.0005
269 CALCIPHYLAXIS 1 0.0005
270 INTESTINAL ISCHAEMIA 3 0.0005
271 INFUSION SITE PAIN 7 0.0005
272 FEEDING DISORDER 11 0.0005
273 CYSTIC FIBROSIS 3 0.0005
274 IRON DEFICIENCY ANAEMIA 5 0.0005
275 COLECTOMY 3 0.0005
276 PARANASAL SINUS HYPERSECRETION 2 0.0005
277 THYROID MASS 2 0.0005
278 ADRENAL DISORDER 1 0.0005
279 MUSCLE RUPTURE 2 0.0005
280 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
281 EPIGASTRIC DISCOMFORT 2 0.0005
282 NAIL DISCOLOURATION 2 0.0005
283 BRADYKINESIA 3 0.0005
284 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
285 OESOPHAGEAL CANDIDIASIS 2 0.0005
286 HYPERPHAGIA 2 0.0005
287 ARTERIOSPASM CORONARY 2 0.0005
288 TRIGEMINAL NEURALGIA 2 0.0005
289 CARDIAC DISCOMFORT 1 0.0005
290 VITAMIN B12 DEFICIENCY 2 0.0005
291 ESCHERICHIA INFECTION 4 0.0005
292 POOR VENOUS ACCESS 5 0.0005
293 AKINESIA 1 0.0005
294 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
295 ANAL PRURITUS 1 0.0005
296 SUICIDAL BEHAVIOUR 2 0.0005
297 SUICIDAL IDEATION 44 0.0005
298 PRE-EXISTING CONDITION IMPROVED 3 0.0005
299 LIMB INJURY 13 0.0005
300 HYPOCALCAEMIA 9 0.0005
301 SLEEP TERROR 2 0.0005
302 THERAPEUTIC RESPONSE CHANGED 3 0.0005
303 HEPATIC PAIN 2 0.0005
304 DYSKINESIA 19 0.0005
305 ABNORMAL SENSATION IN EYE 2 0.0005
306 TENSION HEADACHE 2 0.0005
307 HAEMORRHOIDS 9 0.0005
308 BEDRIDDEN 6 0.0005
309 ABDOMINAL PAIN 106 0.0005
310 APPETITE DISORDER 3 0.0005
311 CARDIAC FAILURE ACUTE 3 0.0004
312 ILEUS PARALYTIC 2 0.0004
313 THERAPY INTERRUPTED 32 0.0004
314 MENINGITIS ASEPTIC 2 0.0004
315 EYE PAIN 25 0.0004
316 SUSPECTED OFF LABEL USE 2 0.0004
317 HEAD INJURY 14 0.0004
318 OPTIC NEURITIS 4 0.0004
319 HAEMOGLOBIN INCREASED 2 0.0004
320 ECCHYMOSIS 3 0.0004
321 DROOLING 3 0.0004
322 EYE OPERATION 2 0.0004
323 NIGHTMARE 15 0.0004
324 BREAKTHROUGH PAIN 1 0.0004
325 TIBIA FRACTURE 2 0.0004
326 HAND FRACTURE 3 0.0004
327 IRRITABLE BOWEL SYNDROME 9 0.0004
328 ENDOMETRIOSIS 2 0.0004
329 IMPAIRED QUALITY OF LIFE 6 0.0004
330 SEROTONIN SYNDROME 8 0.0004
331 VULVOVAGINAL PAIN 2 0.0004
332 VISUAL FIELD DEFECT 3 0.0004
333 GASTROINTESTINAL DISORDER 37 0.0004
334 BREATH ODOUR 1 0.0004
335 PHARYNGEAL SWELLING 4 0.0004
336 PSYCHIATRIC SYMPTOM 3 0.0004
337 BREATH SOUNDS ABNORMAL 2 0.0004
338 HYPERVOLAEMIA 2 0.0004
339 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
340 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
341 ILLNESS 41 0.0004
342 DIVERTICULITIS 11 0.0004
343 HEADACHE 248 0.0004
344 KLEBSIELLA INFECTION 2 0.0004
345 MUSCLE TWITCHING 9 0.0004
346 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
347 MUSCULOSKELETAL CHEST PAIN 6 0.0004
348 CONCUSSION 3 0.0004
349 VARICOSE VEIN 2 0.0004
350 MULTIPLE ALLERGIES 3 0.0004
351 AFFECTIVE DISORDER 3 0.0004
352 GASTRITIS 10 0.0004
353 HALLUCINATION, VISUAL 8 0.0004
354 INCONTINENCE 4 0.0004
355 ABDOMINAL DISCOMFORT 63 0.0004
356 ANIMAL BITE 1 0.0004
357 FOOD POISONING 2 0.0004
358 ANAL FISSURE 2 0.0004
359 RHINITIS 3 0.0004
360 FRUSTRATION TOLERANCE DECREASED 3 0.0004
361 BLOOD SODIUM INCREASED 1 0.0004
362 STRESS FRACTURE 2 0.0004
363 HIP SURGERY 2 0.0004
364 BACK DISORDER 6 0.0004
365 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
366 HEMIPLEGIA 3 0.0004
367 NERVE INJURY 4 0.0004
368 DEPRESSED MOOD 19 0.0004
369 HEART RATE ABNORMAL 2 0.0004
370 BREAST CANCER STAGE IV 1 0.0004
371 DEPRESSION 80 0.0004
372 PRODUCT PHYSICAL ISSUE 7 0.0003
373 MUSCLE STRAIN 3 0.0003
374 PARAESTHESIA ORAL 5 0.0003
375 SKIN SWELLING 3 0.0003
376 ADENOVIRUS INFECTION 1 0.0003
377 ORTHOSTATIC HYPOTENSION 6 0.0003
378 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
379 HYPOKINESIA 5 0.0003
380 URINE OUTPUT DECREASED 3 0.0003
381 PRODUCT COMMUNICATION ISSUE 3 0.0003
382 SLEEP DISORDER 24 0.0003
383 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
384 BLOOD IRON DECREASED 4 0.0003
385 PLEURISY 2 0.0003
386 ABDOMINAL PAIN UPPER 69 0.0003
387 BLOOD CULTURE POSITIVE 1 0.0003
388 OROPHARYNGEAL DISCOMFORT 3 0.0003
389 HALLUCINATION 25 0.0003
390 SMALL INTESTINAL OBSTRUCTION 4 0.0003
391 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
392 TENDON RUPTURE 4 0.0003
393 LIMB DISCOMFORT 10 0.0003
394 SCOLIOSIS 2 0.0003
395 THINKING ABNORMAL 6 0.0003
396 MENTAL DISORDER 14 0.0003
397 FLANK PAIN 3 0.0003
398 SECRETION DISCHARGE 4 0.0003
399 BLOOD CREATININE DECREASED 1 0.0003
400 SWELLING OF EYELID 2 0.0003
401 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
402 ABDOMINAL ADHESIONS 1 0.0003
403 SPUTUM DISCOLOURED 3 0.0003
404 INTENTIONAL DOSE OMISSION 9 0.0003
405 FEELING JITTERY 6 0.0003
406 SLEEP APNOEA SYNDROME 6 0.0003
407 SCREAMING 2 0.0003
408 FOREIGN BODY SENSATION IN EYES 2 0.0003
409 LETHARGY 18 0.0003
410 ENTERITIS 2 0.0003
411 POST PROCEDURAL COMPLICATION 6 0.0003
412 ERUCTATION 6 0.0003
413 HERPES SIMPLEX 2 0.0003
414 INFLAMMATORY BOWEL DISEASE 3 0.0003
415 COELIAC DISEASE 3 0.0003
416 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
417 VITREOUS FLOATERS 3 0.0003
418 SOMNAMBULISM 2 0.0003
419 URINARY INCONTINENCE 9 0.0003
420 DYSGRAPHIA 2 0.0003
421 TOOTH INFECTION 4 0.0003
422 WALKING AID USER 2 0.0003
423 PRODUCT FORMULATION ISSUE 2 0.0003
424 SARS-COV-2 TEST POSITIVE 4 0.0003
425 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 61 0.0003
426 OVARIAN CYST 3 0.0003
427 SPINAL FRACTURE 6 0.0003
428 VISION BLURRED 41 0.0003
429 PRODUCT USE IN UNAPPROVED INDICATION 74 0.0003
430 COLITIS ISCHAEMIC 2 0.0003
431 POSTOPERATIVE WOUND INFECTION 2 0.0003
432 SINUS CONGESTION 4 0.0003
433 ULCER HAEMORRHAGE 2 0.0003
434 PRODUCT LABEL ISSUE 2 0.0003
435 ABNORMAL LOSS OF WEIGHT 2 0.0003
436 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
437 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
438 TEMPERATURE INTOLERANCE 3 0.0003
439 SURGERY 17 0.0003
440 LARGE INTESTINE POLYP 2 0.0003
441 LARGE INTESTINE PERFORATION 2 0.0003
442 PRESYNCOPE 7 0.0003
443 NEURALGIA 7 0.0003
444 POLLAKIURIA 12 0.0003
445 WEIGHT FLUCTUATION 3 0.0003
446 DIARRHOEA 185 0.0003
447 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
448 SINUSITIS 29 0.0003
449 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
450 BODY HEIGHT DECREASED 3 0.0003
451 BIPOLAR DISORDER 3 0.0003
452 PRODUCT DOSE OMISSION ISSUE 81 0.0003
453 FAECES SOFT 2 0.0003
454 RESTLESS LEGS SYNDROME 5 0.0003
455 HYPOPHAGIA 7 0.0003
456 MOUTH HAEMORRHAGE 2 0.0003
457 PRODUCTIVE COUGH 13 0.0003
458 AMYLASE INCREASED 1 0.0003
459 PSYCHOTIC DISORDER 8 0.0003
460 HYPOPHOSPHATAEMIA 2 0.0003
461 VIRAL INFECTION 9 0.0003
462 FUNGAL INFECTION 9 0.0003
463 ARTHROPOD BITE 2 0.0003
464 GAIT INABILITY 9 0.0003
465 MALNUTRITION 3 0.0003
466 BACTERIAL INFECTION 5 0.0003
467 SKIN INFECTION 3 0.0003
468 OCULAR DISCOMFORT 3 0.0003
469 PHOTOPHOBIA 5 0.0003
470 EYE INFECTION 3 0.0003
471 AUTOIMMUNE THYROIDITIS 1 0.0003
472 DERMATITIS CONTACT 3 0.0003
473 SCAB 3 0.0003
474 FEELING ABNORMAL 63 0.0003
475 MICTURITION URGENCY 3 0.0003
476 INCREASED APPETITE 5 0.0003
477 DRY EYE 13 0.0003
478 POST PROCEDURAL HAEMORRHAGE 3 0.0003
479 MOOD ALTERED 7 0.0003
480 MUSCLE SPASMS 47 0.0003
481 GASTROINTESTINAL INFLAMMATION 2 0.0003
482 DIZZINESS 127 0.0003
483 NAUSEA 201 0.0003
484 SINUS DISORDER 5 0.0003
485 FURUNCLE 2 0.0003
486 ACCIDENT 3 0.0003
487 UPPER LIMB FRACTURE 5 0.0003
488 SCIATICA 4 0.0003
489 AZOTAEMIA 1 0.0003
490 THYROID CANCER 3 0.0002
491 PANIC ATTACK 9 0.0002
492 INJURY ASSOCIATED WITH DEVICE 5 0.0002
493 ADVERSE DRUG REACTION 22 0.0002
494 MUSCLE SPASTICITY 3 0.0002
495 CHOLELITHIASIS 8 0.0002
496 MANIA 4 0.0002
497 RIB FRACTURE 5 0.0002
498 DYSPHAGIA 23 0.0002
499 MENSTRUAL DISORDER 2 0.0002
500 EOSINOPHIL COUNT INCREASED 2 0.0002
501 DYSARTHRIA 9 0.0002
502 CANDIDA INFECTION 4 0.0002
503 MUSCLE ATROPHY 3 0.0002
504 ANGER 8 0.0002
505 HEMIPARESIS 4 0.0002
506 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
507 AORTIC VALVE INCOMPETENCE 1 0.0002
508 EATING DISORDER 5 0.0002
509 IMPAIRED WORK ABILITY 5 0.0002
510 COVID-19 41 0.0002
511 ROTATOR CUFF SYNDROME 3 0.0002
512 PSEUDOMONAS INFECTION 2 0.0002
513 HIATUS HERNIA 3 0.0002
514 DIPLOPIA 6 0.0002
515 HYSTERECTOMY 2 0.0002
516 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
517 PALPITATIONS 27 0.0002
518 RESPIRATORY TRACT INFECTION 6 0.0002
519 DISCOMFORT 14 0.0002
520 CONTUSION 22 0.0002
521 GROIN PAIN 2 0.0002
522 IMMUNOSUPPRESSION 2 0.0002
523 HEAD DISCOMFORT 4 0.0002
524 VOMITING 106 0.0002
525 ANXIETY 64 0.0002
526 EYE HAEMORRHAGE 3 0.0002
527 BRAIN NEOPLASM MALIGNANT 1 0.0002
528 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
529 SNEEZING 5 0.0002
530 THERAPY NON-RESPONDER 10 0.0002
531 HEAVY MENSTRUAL BLEEDING 2 0.0002
532 CRYING 8 0.0002
533 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
534 MOOD SWINGS 7 0.0002
535 WEIGHT DECREASED 61 0.0002
536 NEPHROLITHIASIS 10 0.0002
537 PNEUMONIA BACTERIAL 2 0.0002
538 INCREASED TENDENCY TO BRUISE 2 0.0002
539 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
540 SEIZURE 25 0.0002
541 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
542 ARTHRITIS INFECTIVE 1 0.0002
543 COORDINATION ABNORMAL 3 0.0002
544 HOSPITALISATION 33 0.0002
545 MIDDLE INSOMNIA 4 0.0002
546 TACHYCARDIA 19 0.0002
547 DEVICE OCCLUSION 3 0.0002
548 DYSPNOEA EXERTIONAL 8 0.0002
549 FOOT FRACTURE 4 0.0002
550 SPEECH DISORDER 11 0.0002
551 EYE INFLAMMATION 2 0.0002
552 DRY MOUTH 17 0.0002
553 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
554 INJECTION SITE SWELLING 16 0.0002
555 DRUG INEFFECTIVE 275 0.0002
556 EYE IRRITATION 12 0.0002
557 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
558 HYPERCHOLESTEROLAEMIA 2 0.0002
559 DEVICE DISLOCATION 9 0.0002
560 HERNIA 4 0.0002
561 DECREASED APPETITE 48 0.0002
562 DIZZINESS POSTURAL 2 0.0002
563 PRODUCT STORAGE ERROR 18 0.0002
564 AUTOIMMUNE DISORDER 2 0.0002
565 GASTRIC DISORDER 7 0.0002
566 KIDNEY INFECTION 4 0.0002
567 PARAESTHESIA 32 0.0002
568 DISABILITY 4 0.0002
569 DISORIENTATION 8 0.0002
570 BLADDER DISORDER 2 0.0002
571 PRESCRIBED UNDERDOSE 4 0.0002
572 SALIVARY HYPERSECRETION 2 0.0002
573 BLOOD POTASSIUM DECREASED 6 0.0002
574 OFF LABEL USE 174 0.0002
575 UNEVALUABLE EVENT 15 0.0002
576 PRODUCT ADMINISTRATION ERROR 4 0.0002
577 HYPOTHERMIA 2 0.0002
578 VERTIGO 12 0.0002
579 INFUSION RELATED REACTION 13 0.0002
580 HIP ARTHROPLASTY 3 0.0002
581 BLOOD PRESSURE DECREASED 13 0.0002
582 INITIAL INSOMNIA 2 0.0002
583 EAR DISCOMFORT 2 0.0002
584 OSTEOPOROSIS 8 0.0002
585 TENDONITIS 3 0.0002
586 DELUSION 3 0.0002
587 DYSPEPSIA 19 0.0002
588 EYE DISCHARGE 2 0.0002
589 THERAPY PARTIAL RESPONDER 3 0.0002
590 HEART RATE INCREASED 19 0.0002
591 PRODUCT ODOUR ABNORMAL 2 0.0002
592 KNEE ARTHROPLASTY 4 0.0002
593 PNEUMOTHORAX 3 0.0002
594 RESPIRATORY TRACT CONGESTION 3 0.0002
595 ULCER 3 0.0002
596 EAR INFECTION 5 0.0002
597 CONDITION AGGRAVATED 57 0.0002
598 JOINT INJURY 4 0.0002
599 LIVER FUNCTION TEST INCREASED 4 0.0002
600 FEAR 5 0.0002
601 FATIGUE 144 0.0002
602 MENSTRUATION DELAYED 2 0.0002
603 OESOPHAGITIS 2 0.0002
604 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
605 PERIPHERAL SWELLING 28 0.0002
606 URINARY TRACT INFECTION 31 0.0002
607 ABNORMAL DREAMS 5 0.0002
608 MOBILITY DECREASED 13 0.0002
609 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
610 FOOT DEFORMITY 2 0.0002
611 FALL 60 0.0002
612 PROCEDURAL PAIN 5 0.0002
613 HYPERTENSIVE CRISIS 2 0.0002
614 CONFUSIONAL STATE 29 0.0002
615 EYE PRURITUS 6 0.0002
616 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
617 INTESTINAL PERFORATION 2 0.0002
618 BLOOD CALCIUM DECREASED 2 0.0002
619 CHROMATURIA 4 0.0002
620 STATUS EPILEPTICUS 2 0.0002
621 HEART RATE IRREGULAR 4 0.0002
622 REBOUND EFFECT 2 0.0002
623 FLUID RETENTION 9 0.0002
624 THERAPY CESSATION 9 0.0002
625 SCAR 3 0.0002
626 HYPERSOMNIA 5 0.0002
627 TINNITUS 8 0.0002
628 DEVICE DEFECTIVE 3 0.0002
629 INFECTION 25 0.0002
630 NERVOUSNESS 9 0.0002
631 ELECTROLYTE IMBALANCE 2 0.0002
632 NEEDLE ISSUE 5 0.0002
633 COGNITIVE DISORDER 8 0.0002
634 DYSSTASIA 5 0.0002
635 BONE PAIN 10 0.0002
636 SPINAL PAIN 2 0.0002
637 DRUG INTERACTION 27 0.0002
638 CATARACT OPERATION 1 0.0002
639 CARDIAC PACEMAKER INSERTION 1 0.0002
640 ROAD TRAFFIC ACCIDENT 7 0.0002
641 BLOOD GLUCOSE DECREASED 8 0.0002
642 OEDEMA 9 0.0002
643 APHASIA 5 0.0002
644 LOCALISED INFECTION 4 0.0002
645 NOCTURIA 2 0.0002
646 ACCIDENTAL OVERDOSE 6 0.0002
647 SOMNOLENCE 33 0.0002
648 BACK PAIN 38 0.0002
649 HAEMATOCHEZIA 9 0.0002
650 DYSURIA 6 0.0002
651 RECTAL HAEMORRHAGE 7 0.0002
652 OROPHARYNGEAL PAIN 15 0.0002
653 INFLUENZA 18 0.0002
654 VISUAL IMPAIRMENT 20 0.0002
655 MEMORY IMPAIRMENT 22 0.0002
656 BLOOD SODIUM DECREASED 3 0.0002
657 BLEPHAROSPASM 1 0.0002
658 CELLULITIS 8 0.0002
659 GASTRIC ULCER 3 0.0002
660 JOINT SWELLING 19 0.0002
661 TREATMENT FAILURE 13 0.0002
662 BURNING SENSATION 11 0.0002
663 TREMOR 26 0.0002
664 CHEST PAIN 29 0.0002
665 PULMONARY OEDEMA 7 0.0002
666 CHEST DISCOMFORT 16 0.0002
667 LOWER LIMB FRACTURE 3 0.0002
668 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
669 THROAT IRRITATION 7 0.0002
670 DRUG INTOLERANCE 15 0.0002
671 NIGHT SWEATS 5 0.0002
672 INFLAMMATION 8 0.0002
673 CARDIAC FLUTTER 1 0.0002
674 DYSTONIA 3 0.0002
675 EAR PAIN 3 0.0002
676 ANGINA UNSTABLE 1 0.0002
677 NASAL CONGESTION 9 0.0002
678 PAIN 94 0.0002
679 DEAFNESS 4 0.0002
680 MALAISE 67 0.0002
681 DERMATITIS ATOPIC 8 0.0002
682 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
683 UNDERDOSE 11 0.0002
684 URINARY RETENTION 5 0.0001
685 JOINT RANGE OF MOTION DECREASED 2 0.0001
686 QUALITY OF LIFE DECREASED 2 0.0001
687 INCORRECT DOSE ADMINISTERED 34 0.0001
688 BREAST MASS 1 0.0001
689 INTENTIONAL SELF-INJURY 3 0.0001
690 BRONCHIECTASIS 1 0.0001
691 TASTE DISORDER 3 0.0001
692 PRODUCT TASTE ABNORMAL 2 0.0001
693 HYPERHIDROSIS 19 0.0001
694 UVEITIS 2 0.0001
695 WEIGHT INCREASED 33 0.0001
696 INSOMNIA 39 0.0001
697 FEELING COLD 4 0.0001
698 NECK PAIN 8 0.0001
699 BLISTER 8 0.0001
700 BLOOD TEST ABNORMAL 2 0.0001
701 MYALGIA 24 0.0001
702 RETCHING 3 0.0001
703 PARALYSIS 2 0.0001
704 CEREBRAL HAEMORRHAGE 5 0.0001
705 POOR QUALITY SLEEP 3 0.0001
706 RHINORRHOEA 9 0.0001
707 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
708 FAECES DISCOLOURED 3 0.0001
709 APATHY 2 0.0001
710 GASTROENTERITIS 2 0.0001
711 AGITATION 10 0.0001
712 ASTHENIA 51 0.0001
713 BLINDNESS TRANSIENT 1 0.0001
714 EYE SWELLING 5 0.0001
715 PULMONARY MASS 2 0.0001
716 COLON CANCER 2 0.0001
717 DEVICE ISSUE 12 0.0001
718 RESPIRATORY DISORDER 4 0.0001
719 HYPOAESTHESIA 20 0.0001
720 ASTHMA 15 0.0001
721 SKIN DISCOLOURATION 6 0.0001
722 FEELING HOT 8 0.0001
723 DEVICE RELATED INFECTION 2 0.0001
724 DISTURBANCE IN ATTENTION 7 0.0001
725 THYROID DISORDER 2 0.0001
726 EMOTIONAL DISORDER 4 0.0001
727 SWELLING 12 0.0001
728 SWOLLEN TONGUE 4 0.0001
729 TREATMENT NONCOMPLIANCE 7 0.0001
730 MUSCULOSKELETAL STIFFNESS 11 0.0001
731 HIP FRACTURE 4 0.0001
732 BLOOD PRESSURE INCREASED 19 0.0001
733 MUSCLE TIGHTNESS 2 0.0001
734 FIBROMYALGIA 3 0.0001
735 INJECTION SITE URTICARIA 3 0.0001
736 PRODUCT SUBSTITUTION ISSUE 7 0.0001
737 INFLUENZA LIKE ILLNESS 10 0.0001
738 STAPHYLOCOCCAL INFECTION 4 0.0001
739 PHOTOSENSITIVITY REACTION 2 0.0001
740 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
741 ACUTE CORONARY SYNDROME 1 0.0001
742 AGEUSIA 3 0.0001
743 PNEUMONIA ASPIRATION 3 0.0001
744 RASH 52 0.0001
745 ABDOMINAL PAIN LOWER 3 0.0001
746 FACE OEDEMA 2 0.0001
747 PRODUCT COMPLAINT 3 0.0001
748 HAEMATEMESIS 3 0.0001
749 HYPERTENSION 25 0.0001
750 DYSPNOEA 66 0.0001
751 SEPSIS 13 0.0001
752 CARDIAC OPERATION 1 0.0001
753 UNRESPONSIVE TO STIMULI 3 0.0001
754 MUSCULOSKELETAL DISCOMFORT 2 0.0001
755 BLOOD MAGNESIUM DECREASED 1 0.0001
756 EXPOSURE VIA SKIN CONTACT 3 0.0001
757 NEUROPATHY PERIPHERAL 11 0.0001
758 ILL-DEFINED DISORDER 7 0.0001
759 DEVICE USE ERROR 4 0.0001
760 GAIT DISTURBANCE 22 0.0001
761 ARTHRITIS 9 0.0001
762 MUSCULAR WEAKNESS 13 0.0001
763 DEVICE USE ISSUE 2 0.0001
764 SYRINGE ISSUE 2 0.0001
765 COUGH 32 0.0001
766 BLOOD CALCIUM INCREASED 1 0.0001
767 NASOPHARYNGITIS 21 0.0001
768 PANCREATITIS 6 0.0001
769 COLD SWEAT 2 0.0001
770 GALLBLADDER DISORDER 2 0.0001
771 PRURITUS 43 0.0001
772 GASTROENTERITIS VIRAL 2 0.0001
773 PNEUMONITIS 3 0.0001
774 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
775 BRAIN NEOPLASM 1 0.0001
776 BLOOD GLUCOSE ABNORMAL 2 0.0001
777 ARTHRALGIA 45 0.0001
778 BRONCHITIS 8 0.0001
779 HEPATIC STEATOSIS 2 0.0001
780 PANCYTOPENIA 6 0.0001
781 DEMENTIA 3 0.0001
782 RENAL DISORDER 5 0.0001
783 PAIN IN JAW 3 0.0001
784 DISEASE RECURRENCE 5 0.0001
785 NEOPLASM MALIGNANT 7 0.0001
786 PULMONARY FIBROSIS 2 0.0001
787 GLAUCOMA 2 0.0001
788 ATRIAL FIBRILLATION 10 0.0001
789 DYSPHONIA 6 0.0001
790 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
791 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
792 ASCITES 3 0.0001
793 LABORATORY TEST ABNORMAL 3 0.0001
794 HAEMATOCRIT DECREASED 2 0.0001
795 PREGNANCY 2 0.0001
796 IRRITABILITY 6 0.0001
797 LACRIMATION INCREASED 3 0.0001
798 EXTRA DOSE ADMINISTERED 4 0.0001
799 PSORIATIC ARTHROPATHY 4 0.0001
800 DEVICE BREAKAGE 4 0.0001
801 BLINDNESS 4 0.0001
802 INJECTION SITE RASH 3 0.0001
803 DRUG ADMINISTRATION ERROR 3 0.0001
804 DEHYDRATION 13 0.0001
805 PRODUCT PREPARATION ERROR 2 0.0001
806 ERYTHEMA 20 0.0001
807 INJECTION SITE WARMTH 2 0.0001
808 ECZEMA 5 0.0001
809 DERMATITIS 2 0.0001
810 WITHDRAWAL SYNDROME 4 0.0001
811 BRADYCARDIA 5 0.0001
812 CYSTITIS 3 0.0001
813 CHILLS 11 0.0001
814 BREAST PAIN 1 0.0001
815 EPISTAXIS 7 0.0001
816 PNEUMONIA 30 0.0001
817 DEVICE LEAKAGE 4 0.0001
818 SWELLING FACE 6 0.0001
819 BACK INJURY 1 0.0001
820 BLOOD GLUCOSE FLUCTUATION 1 0.0001
821 EYE DISORDER 3 0.0001
822 APPLICATION SITE PAIN 2 0.0001
823 ANAPHYLACTIC REACTION 5 0.0001
824 EXPIRED PRODUCT ADMINISTERED 3 0.0001
825 LIP SWELLING 3 0.0001
826 SKIN DISORDER 3 0.0001
827 TOOTH DISORDER 2 0.0001
828 RASH PAPULAR 2 0.0001
829 OXYGEN SATURATION DECREASED 5 0.0001
830 FLUSHING 9 0.0001
831 HEPATIC ENZYME INCREASED 6 0.0001
832 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
833 THROMBOSIS 7 0.0001
834 HYPOKALAEMIA 4 0.0001
835 HYPERSENSITIVITY 16 0.0001
836 LOSS OF CONSCIOUSNESS 11 0.0001
837 ATAXIA 1 0.0001
838 PULMONARY EMBOLISM 8 0.0001
839 URTICARIA 14 0.0001
840 BLOOD PRESSURE FLUCTUATION 2 0.0001
841 RENAL IMPAIRMENT 7 0.0001
842 CEREBROVASCULAR ACCIDENT 14 0.0001
843 HYPOGLYCAEMIA 4 0.0001
844 BURSITIS 1 0.0001
845 HYPERGLYCAEMIA 3 0.0001
846 PAIN IN EXTREMITY 24 0.0001
847 ENCEPHALOPATHY 2 0.0001
848 BRAIN OEDEMA 1 0.0001
849 COLITIS 3 0.0001
850 CHRONIC KIDNEY DISEASE 6 0.0001
851 GASTRIC CANCER 2 0.0001
852 PYREXIA 27 0.0001
853 ERECTILE DYSFUNCTION 2 0.0001
854 DRUG RESISTANCE 2 0.0001
855 DEEP VEIN THROMBOSIS 5 0.0001
856 AMNESIA 5 0.0001
857 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
858 MUSCULOSKELETAL PAIN 4 0.0001
859 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
860 JOINT STIFFNESS 2 0.0001
861 ANKYLOSING SPONDYLITIS 1 0.0001
862 ABNORMAL BEHAVIOUR 3 0.0001
863 CARDIAC DISORDER 7 0.0001
864 HYPOTENSION 15 0.0001
865 MENSTRUATION IRREGULAR 2 0.0001
866 PAIN OF SKIN 2 0.0001
867 THROAT TIGHTNESS 2 0.0001
868 OEDEMA PERIPHERAL 9 0.0001
869 NEUTROPHIL COUNT DECREASED 3 0.0001
870 PALLOR 2 0.0001
871 AKATHISIA 1 0.0001
872 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
873 INJECTION SITE ERYTHEMA 9 0.0001
874 MENTAL STATUS CHANGES 2 0.0001
875 WOUND 2 0.0001
876 CARPAL TUNNEL SYNDROME 1 0.0001
877 TARDIVE DYSKINESIA 2 0.0001
878 BRONCHOSPASM 1 0.0001
879 RED BLOOD CELL COUNT DECREASED 2 0.0001
880 HERPES ZOSTER 4 0.0001
881 ACCIDENTAL UNDERDOSE 1 0.0001
882 BALANCE DISORDER 6 0.0001
883 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
884 SEPTIC SHOCK 3 0.0001
885 ACUTE MYOCARDIAL INFARCTION 2 0.0001
886 CARDIOMYOPATHY 1 0.0001
887 HEPATIC FAILURE 2 0.0001
888 THERAPEUTIC RESPONSE DECREASED 4 0.0001
889 SUICIDE ATTEMPT 4 0.0001
890 SKIN IRRITATION 3 0.0001
891 INJECTION SITE PAIN 20 0.0001
892 ANKLE FRACTURE 1 0.0001
893 FEMUR FRACTURE 2 0.0001
894 BREAST CANCER 6 0.0001
895 BLOOD CHOLESTEROL INCREASED 3 0.0001
896 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
897 ACUTE MYELOID LEUKAEMIA 1 0.0001
898 NERVOUS SYSTEM DISORDER 2 0.0001
899 BONE DENSITY DECREASED 2 0.0001
900 RASH ERYTHEMATOUS 3 0.0001
901 MULTIPLE SCLEROSIS 3 0.0001
902 ABSCESS 1 0.0001
903 HYPOTHYROIDISM 2 0.0001
904 MOVEMENT DISORDER 2 0.0001
905 RHEUMATOID ARTHRITIS 7 0.0001
906 BLOOD POTASSIUM INCREASED 1 0.0001
907 IMPAIRED HEALING 2 0.0001
908 DRY SKIN 8 0.0001
909 TYPE 2 DIABETES MELLITUS 2 0.0001
910 HAEMATURIA 2 0.0001
911 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
912 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
913 ANAEMIA 11 0.0001
914 DELIRIUM 2 0.0001
915 HAEMORRHAGE 6 0.0001
916 RASH MACULAR 2 0.0001
917 INTENTIONAL PRODUCT MISUSE 5 0.0001
918 HYPERKALAEMIA 2 0.0001
919 INJURY 4 0.0001
920 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
921 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
922 PLATELET COUNT DECREASED 6 0.0001
923 C-REACTIVE PROTEIN INCREASED 2 0.0001
924 RESPIRATORY FAILURE 4 0.0001
925 DYSGEUSIA 4 0.0001
926 PSORIASIS 7 0.0001
927 BLOOD URINE PRESENT 1 0.0001
928 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
929 ACUTE RESPIRATORY FAILURE 1 0.0001
930 PRODUCT QUALITY ISSUE 7 0.0001
931 CATARACT 3 0.0001
932 BLOOD PRESSURE ABNORMAL 1 0.0001
933 INJECTION SITE BRUISING 4 0.0001
934 SYNCOPE 5 0.0000
935 EMOTIONAL DISTRESS 6 0.0000
936 STOMATITIS 3 0.0000
937 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
938 SKIN EXFOLIATION 4 0.0000
939 OSTEOARTHRITIS 2 0.0000
940 HYPOACUSIS 2 0.0000
941 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
942 PRODUCT DOSE OMISSION 3 0.0000
943 ANGIOEDEMA 2 0.0000
944 DEATH 38 0.0000
945 APPLICATION SITE PRURITUS 1 0.0000
946 DEVICE MALFUNCTION 3 0.0000
947 OCULAR HYPERAEMIA 2 0.0000
948 SKIN BURNING SENSATION 3 0.0000
949 LUNG DISORDER 2 0.0000
950 LEUKOPENIA 2 0.0000
951 HOT FLUSH 3 0.0000
952 DIABETES MELLITUS 3 0.0000
953 ANAPHYLACTIC SHOCK 1 0.0000
954 ANHEDONIA 1 0.0000
955 INJECTION SITE HAEMORRHAGE 3 0.0000
956 CARDIAC FAILURE 3 0.0000
957 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
958 ARTHROPATHY 2 0.0000
959 MEDICATION ERROR 2 0.0000
960 ALOPECIA 7 0.0000
961 HYPONATRAEMIA 2 0.0000
962 MYOCARDIAL INFARCTION 6 0.0000
963 DISEASE PROGRESSION 4 0.0000
964 WHEEZING 2 0.0000
965 ADVERSE EVENT 3 0.0000
966 BLOOD GLUCOSE INCREASED 6 0.0000
967 INTENTIONAL OVERDOSE 2 0.0000
968 DRUG DEPENDENCE 5 0.0000
969 BLOOD CREATININE INCREASED 2 0.0000
970 DEVICE DIFFICULT TO USE 2 0.0000
971 INJECTION SITE PRURITUS 2 0.0000
972 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
973 HAEMOGLOBIN DECREASED 3 0.0000
974 INJECTION SITE REACTION 2 0.0000
975 ACNE 2 0.0000
976 DRUG DOSE OMISSION BY DEVICE 2 0.0000
977 ABORTION SPONTANEOUS 1 0.0000
978 CARDIAC ARREST 2 0.0000
979 DRUG ABUSE 2 0.0000
980 COMPLETED SUICIDE 2 0.0000
981 RENAL FAILURE 3 0.0000
982 NEUTROPENIA 3 0.0000
983 ARRHYTHMIA 1 0.0000
984 AGGRESSION 1 0.0000
985 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
986 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
987 CARDIAC FAILURE CONGESTIVE 1 0.0000
988 OVERDOSE 2 0.0000
989 ACUTE KIDNEY INJURY 1 0.0000